Related references
Note: Only part of the references are listed.Improving the Treatment of Non-Hodgkin Lymphoma With Antibody-Targeted Radionuclides
Robert M. Sharkey et al.
CANCER (2010)
Antifungal Therapy with Itraconazole Impairs the Anti-Lymphoma Effects of Rituximab by Inhibiting Recruitment of CD20 to Cell Surface Lipid Rafts
Ingo Ringshausen et al.
CANCER RESEARCH (2010)
Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
Sid P. Kerkar et al.
CANCER RESEARCH (2010)
Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor
Yangbing Zhao et al.
CANCER RESEARCH (2010)
Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer
Rajeev K. Shrimali et al.
CANCER RESEARCH (2010)
Adjuvant engineering for cancer immunotherapy: Development of a synthetic TLR2 ligand with increased cell adhesion
Takashi Akazawa et al.
CANCER SCIENCE (2010)
Development of a Murine model to dissect the CpG-oligonucleotide-enhancement of the killing of human B Cells by rituximab
Virginie Buhe et al.
JOURNAL OF AUTOIMMUNITY (2010)
Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma
Ying Xie et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Adoptive Transfer of Tumor-Specific Tc17 Effector T Cells Controls the Growth of B16 Melanoma in Mice
Maria de la Luz Garcia-Hernandez et al.
JOURNAL OF IMMUNOLOGY (2010)
Intratumoral Neoadjuvant Immunotherapy Using IL-12 and Dendritic Cells Is an Effective Strategy To Control Recurrence of Murine Hepatocellular Carcinoma in Immunosuppressed Mice
Hiroto Kayashima et al.
JOURNAL OF IMMUNOLOGY (2010)
The Inducible Costimulator (ICOS) Is Critical for the Development of Human TH17 Cells
Chrystal M. Paulos et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Bacteriolytic therapy of experimental pancreatic carcinoma
Claudia Maletzki et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
It is the antigen(s), stupid and other lessons from over a decade of vaccitherapy of human cancer
Matthew R. Buckwalter et al.
SEMINARS IN IMMUNOLOGY (2008)
Cancer immunotherapy and preclinical studies: Why we are not wasting our time with animal experiments
Karin Schreiber et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2006)
Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancer
SE Finkelstein et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Share Paper
